Skip to main content
Ovarian Cancer
NORA Clinical Trial Confirms Efficacy of Individualized Niraparib Starting Dose to Treat Platinum-Sensitive Ovarian Cancer
Read More
Ovarian Cancer
Increased Uptake of Neoadjuvant Chemotherapy Does Not Explain Trend Toward Improved Survival in Advanced Ovarian Cancer
Read More
Ovarian Cancer
Platinum-Based Chemotherapy Following Progression on PARP Inhibitor Maintenance Yields Greatest Benefit in Advanced Ovarian Cancer with Platinum-Free Interval >12 Months
Read More
Practical Issues in Pharmacy Management
Exploring the Occupational Hazards Associated with Antineoplastic Agents
Jeff Lombardo, PharmD, BCOP
Read More
FDA Updates
Gavreto, RET Inhibitor, FDA Approved for Metastatic NSCLC with RET Fusions
Read More
Meeting Highlights
ESMO Highlights
Adjuvant Abemaciclib plus Endocrine Therapy Game-Changer in High-Risk, HR-Positive, HER2-Negative Early Breast Cancer
Phoebe Starr
Read More
Original Research, Transplant, Adverse Events
Horsies and Bunnies: Comparing Antithymocyte Globulin Drugs in Patients Undergoing Allogeneic Stem-Cell Transplant
Crystal Lu, PharmD, BCOP, Nancy Mikulandric, PharmD, BCOP, Meredith Grycki, PharmD, BCOP, BCPS, Vishnuprabha Vogel, PharmD, BCOP, BCPS, Shatha Farhan, MD, Edward Peres, MD, Nalini Janakiraman, MD, Klodiana Neme, PharmD, BCOP
Crystal Lu, PharmD, BCOP; Nancy Mikulandric, PharmD, BCOP; Meredith Grycki, PharmD, BCOP, BCPS; Vishnuprabha Vogel, PharmD, BCOP, BCPS; Shatha Farhan, MD; Edward Peres, MD; Nalini Janakiraman, MD; Klodiana Neme, PharmD, BCOP
Read More
Original Research, Oral Therapy, Thromboembolism
Evaluation of Direct Oral Anticoagulant Use for Cancer-Associated Thromboembolism
Sarah E. Wheeler, PharmD, Laurie Matt-Amaral, MD, MPH, Chanda Mullen, PhD, Caroline Townley, PharmD, Melanie L. Boros, PharmD, BCPS, BCACP
Sarah E. Wheeler, PharmD; Laurie Matt-Amaral, MD, MPH; Chanda Mullen, PhD; Caroline P. Townley, PharmD, BCOP; Melanie L. Boros, PharmD, BCPS, BCACP
Read More
Case Reports, Dose Escalation/Reduction, Prostate Cancer
Enzalutamide Administration for a Nonhemodialysis Patient with Stage 4 Chronic Kidney Disease and Nonmetastatic Castration-Resistant Prostate Cancer
So Jung Uhm, PharmD, John Malamakal, PharmD, MS, BCPS, BCOP
So Jung Uhm, PharmD; John Malamakal, PharmD, MS, BCPS, BCOP
Read More
Case Reports, Dose Escalation/Reduction, Adverse Events
Dexamethasone-Sparing Strategies Using Netupitant and Palonosetron Fixed-Dose Combination for Prophylaxis of Chemotherapy-Induced Nausea and Vomiting: A Case Series
Volkmar Böhme, MD, Ee Min Yeoh, BSc Pharm
Volkmar Böhme, MD; Ee Min Yeoh, BSc Pharm
Read More
Page 130 of 200
Results 1291 - 1300 of 1993